Provided by Tiger Fintech (Singapore) Pte. Ltd.

GRAND PHARMA

8.980
+0.1802.05%
Volume:11.85M
Turnover:106.06M
Market Cap:31.88B
PE:12.74
High:9.080
Open:8.870
Low:8.820
Close:8.800
52wk High:10.200
52wk Low:3.862
Shares:3.55B
HK Float Shares:3.55B
Volume Ratio:0.72
T/O Rate:0.33%
Dividend:0.26
Dividend Rate:2.90%
EPS(LYR):0.705
ROE:12.37%
ROA:4.77%
PB:1.86
PE(LYR):12.74
PS:2.72

Loading ...

FDA Approves Grand Pharmaceutical Group's Innovative SIR-Spheres Y-90 Resin Microsphere Injection Ahead of Schedule

Reuters
·
Jul 07

Grand Pharmaceutical Enrolls Patients in Eye Drop Phase 3 Clinical Trial

MT Newswires Live
·
Jun 04

Shanghai Bio-heart Launches New Kidney Treatment Device

MT Newswires Live
·
Jun 04

Grand Pharma's Demodex Blepharitis Treatment Approved in Macau; Shares Down 3%

MT Newswires Live
·
May 26

Grand Pharmaceutical Group Ltd. Announces Approval for Commercialization of Innovative Demodex Blepharitis Treatment by Macao ISAF of China

Reuters
·
May 25

Grand Pharmaceutical Gets China Radiation Safety License for Chengdu Nuclear Medicine Facility

MT Newswires Live
·
May 19

Grand Pharmaceutical Group Ltd. Obtains Class A "Radiation Safety License" for Nuclear Medicine R&D Base, Operations to Start in June

Reuters
·
May 18

Grand Pharmaceutical Gets China Nod for Phase 3 Studies of Prostate Cancer Drug

MT Newswires Live
·
May 08

BRIEF-Grand Pharmaceutical Says NMPA Accepts Application For Group's RDC TLX591

Reuters
·
May 07

Grand Pharmaceutical's Phase 2 Trial for Sepsis Drug Achieves Clinical Endpoints

MT Newswires Live
·
May 06

Grand Pharmaceutical's Hepatocellular Carcinoma Diagnosis Drug Exhibits Safety, Efficacy in Trial

MT Newswires Live
·
Apr 22

Grand Pharmaceutical Gets Registration Certificate for Nasal Spray in China

MT Newswires Live
·
Apr 22

BRIEF-Grand Pharmaceutical's Fluticasone Propionate Nasal Spray Approved For Commercialization in China

Reuters
·
Apr 22

There's A Lot To Like About Grand Pharmaceutical Group's (HKG:512) Upcoming HK$0.26 Dividend

Simply Wall St.
·
Apr 09

Grand Pharma Group Doses First Patient in Tumor Drug Clinical Trial

MT Newswires Live
·
Mar 20